Research
Zero-Shot Prognostic Covariate Adjustment and Mechanistic Week-1 Myelosuppression Updating Across 9,500 Oncology Patients Under FDA Guidance
The preprint tests both models on about 9,500 patients: control arms from 14 randomized trials and three AACR Project GENIE cohorts. On three held-out trials scored once after locking, the index removed 11% to 18% of overall-survival variance.